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Spontaneous Cardiomyocyte Differentiation From Adipose
Tissue Stroma Cells
V. Planat-Bénard, C. Menard, M. André, M. Puceat, A. Perez,
J.-M. Garcia-Verdugo, L. Pénicaud, L. Casteilla
Abstract—Cardiomyocyte regeneration is limited in adult life. Thus, the identification of a putative source of
cardiomyocyte progenitors is of great interest to provide a usable model in vitro and new perspective in
regenerative therapy. As adipose tissues were recently demonstrated to contain pluripotent stem cells, the
emergence of cardiomyocyte phenotype from adipose-derived cells was investigated. We demonstrated that rare
beating cells with cardiomyocyte features could be identified after culture of adipose stroma cells without addition
of 5-azacytidine. The cardiomyocyte phenotype was first identified by morphological observation, confirmed with
expression of specific cardiac markers, immunocytochemistry staining, and ultrastructural analysis, revealing the
presence of ventricle- and atrial-like cells. Electrophysiological studies performed on early culture revealed a
pacemaker activity of the cells. Finally, functional studies showed that adrenergic agonist stimulated the beating
rate whereas cholinergic agonist decreased it. Taken together, this study demonstrated that functional cardiomyo-
cyte-like cells could be directly obtained from adipose tissue. According to the large amount of this tissue in adult
mammal, it could represent a useful source of cardiomyocyte progenitors. (Circ Res. 2004;94:223-229.)
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Cardiomyocyte differentiation mainly takes place duringneonatal and perinatal life. In adult life, the regenerative
potential of cardiac tissue is limited and is not sufficient to
prevent from the degeneration occurring in pathological
conditions such as myocardial infarction.1 Cell transplanta-
tion seems to be an alternative to overcome this problem.2
This led to numerous investigations to identify a putative
source of transplanted cells and to better understand cardio-
myocyte proliferation and differentiation in order to drive the
fate of stem cells toward this process. Different sources, ie,
embryonic, fetal, and adult cells have been investigated and
tested.3–8 Among them, mesenchymal stem cells (MSCs)
isolated from bone marrow are accepted to give rise to
connective tissue cell types. Their differentiation toward
cardiomyocyte was obtained in vitro and in vivo. However,
immortalized MSCs and treatment with the DNA demethyl-
ation agent 5-azacytidine was necessary to reveal their
cardiogenic potential in vitro.6
Adipose tissues are mesodermic tissues, which develop
during perinatal and postnatal life.9 They are strongly in-
volved in various metabolic disorders such as obesity. Tre-
mendous changes in adipose mass are achieved through
highly controlled processes such as angiogenesis, precursor
recruitment, proliferation, differentiation, dedifferentiation,
and apoptosis as well. More recently, differentiation of cells
derived or purified from adipose tissue toward phenotypes
different from adipocyte was described.10–13 However, the char-
acterization of cells with such potential remains to be done. The
present statement is that adipose tissue consists of mature
adipocytes and the stroma vascular fraction (SVF). SVF is a
heterogeneous cell population. Among them the identified ones
are vascular cells (endothelial, smooth muscle cell, circulating
blood cells) and an undefined fibroblast-like cell population
recently described as a multipotential stem cell population for
various mesodermic lineage.10–13
This led us to test the in vitro cardiomyogenic potential of
cells purified from adipose tissue. In the results reported in
this study, adipose-derived cells (SVF cells) from primary
culture spontaneously differentiate into cells with morpho-
logical, molecular, and functional properties of
cardiomyocytes.
Materials and Methods
Animals
Six-week-old adult male C57Bl/6N mice (Harlan, France) were
housed in conventional animal quarters (SPS barrier facility). Mice
were killed by cervical dislocation under CO2 anesthesia. All
procedures were performed according to SELASA norms.
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Cell Culture
Cells from the stroma vascular fraction were isolated according to
Björntorp et al14 with slight modifications. Briefly, inguinal and
interscapular adipose tissues were digested at 37°C in phosphate
buffer PBS containing 2% BSA and 2 mg/mL collagenase for 45
minutes (collagenase A, Roche). After filtration through 25-m
filters and centrifugation, isolated SVF cells were suspended in PBS,
counted with a hemocytometer, and plated at 7.103 cells/mL in 1.5
mL of MethoCult GF M3534 (StemCell Technologies). The cultured
conditions referred as minimum medium contained basic 1% meth-
ylcellulose in Iscvove’s MDM (MethoCult M3134) added with 1%
bovine serum albumin, 15% fetal bovine serum, 2-mercaptoethanol
(104 mol/L), L-glutamine (2 mmol/L), recombinant human insulin
(10 g/mL), and human transferrin (200 g/mL). The complete
methylcellulose medium mostly used in our experiments (MethoCult
GF M3534) consisted of the same medium enriched with recombi-
nant murine IL-3 (10 ng/mL), recombinant human IL-6 (10 ng/mL),
and recombinant mouse SCF (50 ng/mL). SVF cells plated in
methylcellulose were observed every 2 days under an inverted
phase-contrast microscope and number as well as morphology of
developing clones was followed.
RNA Extraction and RT-PCR Analysis
Total RNA from cells dissected in contracting areas from SVF
culture and RNA from mouse heart were extracted using RNABle
extraction solution (Eurobio). cDNA was synthesized from 2 g
total RNA using 100 U of reverse transcriptase (SuperScript II,
GibcoBRL) and 0.5 g oligodT (Amersham).15 After a 10-minute
denaturation at 70°C, buffer containing 2 mmol/L dNTP and 40 U
RNAsin inhibitor was added in a 10-L final volume. After 5
minutes at 42°C, RT was added and reverse transcription was
performed for 50 minutes at 42°C and stopped by heating 15 minutes
at 72°C. cDNA samples were subjected to PCR amplification with
primers as described in the Table. For GATA-4, MLC-2a, MLC-2v,
ANF, and Nkx2.5 amplifications, 2 L of the RT reaction mixture
was added to a PCR mix containing 1.5 mmol/L MgCl2,
0.05 mmol/L dNTP, and 0.2 pmol/L of each primer and 1.5 U of Taq
polymerase (Promega). For MyoD amplifications, 2 L of the RT
reaction mixture was added to a PCR mix containing 1 mmol/L
MgCl2, 0.05 mmol/L dNTP, and 0.2 pmol/L of each primer and
0.625 U of Taq polymerase (Promega).
For GATA-4 and MyoD, PCR were performed over 36 cycles,
consisting of an initial denaturation at 94°C for 5 minutes, then 94°C
for 30 seconds, 58°C (GATA-4) or 60°C (MyoD) for 30 seconds,
72°C for 30 seconds, and was terminated by a final extension at 72°C
for 8 minutes. Nkx2.5 PCR consisted of denaturation at 94°C for 5
minutes followed by 30 cycles of 95°C for 30 seconds, 58°C for 1
minute 30 seconds, 72°C for 1 minute, and a final extension at 72°C
for 7 minutes. For MLC-2v, MLC-2a, and ANF, each sample was
initially denatured at 94°C for 4 minutes, followed by 5 cycles of
denaturation at 94°C for 45 seconds, annealing at 57°C, 58°C, and
60°C, respectively, for 1 minute, extension at 72°C for 2 minutes,
and 30 cycles of denaturation at 94°C for 45 seconds, annealing at
50°C for 1 minute, extension at 72°C for 2 minutes, and 72°C for 10
minutes. -Actin was used as the control. The PCR products were
size fractionated by 2% agarose gel electrophoresis.
Immunocytochemistry
For confocal microscopy, adherent cells grown in chamber slides
were washed out from methylcellulose with PBS then fixed with 3%
paraformaldehyde or cooled (20°C) in methanol-acetone (50/50)
solution, permeabilized with 0.1% Triton X-100, and labeled with
mouse anti-sarcomeric -actinin antibody 1:500 (Sigma), rabbit
anti-MEF2C antibody 1:50 (Cell Signaling), mouse anti–-MHC
antibody, anti-connexin43 1:50 (Zymed), anti-connexin40 (Chemi-
con), anti-MLC2v 1:50 (Biocytex, France), and alexa546 conjugated
anti-mouse or anti-rabbit IgG (Molecular Probes) (dilution 1:300). In
situ immunostained proteins were visualized in 0.2-m optically
z-sectioned cells. To improve resolution and signal-to-noise ratio,
images were restored using the Huygens software (Huygens 2.2.1,
Scientific Volume Imaging) and visualized using Imaris (Bitplane).
Calculations were performed on DELL Precision 450 workstations.
For phase-contrast microscopy, adherent cells grown in chamber
slides were washed out from methylcellulose with PBS then fixed
and permeabilized overnight at 4°C in 3.7% paraformaldehyde/PBS
buffer. Endogenous peroxidase activity was removed by a 10-minute
incubation in peroxidase blocking reagent (DAKO A/S, Glostrup,
Denmark). After 1 hour of blocking in 1% milk, 0.25% Triton
X-100/PBS buffer, cells were incubated for 1 hour with primary
antibody monoclonal anti-smooth muscle actin 1:50 and monoclonal
anti-MyoD 1:50 (DAKO). After washing in 1% milk PBS buffer,
secondary antibody HRP conjugate (Jackson) was added for 45
minutes. Visualization was achieved through the peroxidase AEC
system (DAKO). Negative controls were performed with purified
mouse IgG and yielded no staining. anti–-MHC antibody was
kindly given by Dr D. Mornet, INSERM, Montpellier, France.
Transmission Electron Microscopy
Cells were washed in phosphate buffer and fixed with 3% glutaral-
dehyde. Samples were postfixed with 0.5% osmium, rinsed, dehy-
drated, and embedded in araldite (Durcupan, Fluka). Semithin
sections (1.5 m) were cut with a diamond knife and stained lightly
with 1% toluidine blue. Semi-thin sections were re-embedded in an
araldite block and detached from the glass slide by repeated freezing
(liquid nitrogen) and thawing. The block with semithin section were
cut in ultrathin (0.05 m) sections with a diamond knife, stained with
lead citrate, and examined under a Jeol 100CX electron microscope.
Electrophysiological Recordings
Cellular electrical activity was recorded at room temperature
(202°C) to reduce beating activity in current-clamp by using the
whole cell configuration.16 The bath solution had the following
composition (in mmol/L): NaCl 140, KCl 5.4, MgCl2 1, CaCl2 1.8,
BaCl2 1, MnCl2 2, HEPES 5.5, and glucose 5. Pipette solution
contained (in mmol/L): KCl 40, NaCl 10, CaCl2 2, MgATP 2, GTP
0.3, EGTA 5, and HEPES 10. Action potentials (AP) data were
acquired using an Axopatch-200 patch-clamp amplifier (Axon In-
struments). Pipettes (3 to 4 M) were prepared on a horizontal
pipette puller (Sutter Instrument CO). Spontaneous electrical activity
RT-PCR Primer Sequences and Product Size
Gene Product Sense Antisense Product Size, bp
GATA4 5-AAGACGCCAGCAGGTCCTGCTGGT-3 5-CGCGGTGATTATGTCCCCATGACT-3 340
Nkx2.5 5-CAGTGGAGCTGGACAAAGCC-3 5-TAGCGACGGTTCTGGAACCA-3 217/217*
MLC-2a 5-GATCATCTGCAAATCAGACCTG-3 5-CTGGGTCATGAGAAGCTGCTTG-3 253/1049*
MLC-2v 5-GCCAAGAAGCGGATAGAAGG-3 5-CTGTGGTTCAGGGCTCAGTC-3 499
ANF 5-TTGGCTTCCAGGCCATA-3 5-AAGAGGGCAGATCTATCGGA-3 282/365*
-Actin 5-ATCGTGGGCCGCCCTAGGCACCA-3 5-TTGGCCTTAGGGTTCAGAGGGG-3 243/330*
MyoD 5-GGAAGAGTGCGGCTGTGT-3 5-CTGTTCTGTGTCGCTTAGGG-3 150
*Size from cDNA amplification/size from genomic DNA amplification.
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appeared between 40 and 60 mV. AP amplitude, time-to-peak,
half amplitude, AP duration at 50% repolarization, rise time 10% to
90%, and instantaneous frequency were determined using the pro-
gram Clampfit 9 (Axon Instruments).
Pharmacological Studies
Elongated fibers with a regular contractile activity were selected and
the basal beating rate was recorded before and after replacement of
methylcellulose culture medium by DMEM-F12 medium containing
10% of newborn calf serum (Life Technologies). Chronotropic
responses were then assessed in DMEM-F12, NCS 10% by extra-
cellular recording of the beating rate in the presence of the appro-
priate drug. Dose-response experiments were performed with 0.25 to
5106 mol/L isoproterenol, 5 to 20106 mol/L propranolol, 0.125
to 2.5106 mol/L carbamylcholine, and 0.5 to 5106 mol/L
atropin. Antagonist was added after the maximal dose of agonist. The
values were represented as meanSEM.
Videotape Recording
The cultured cells were observed through an inverted-type phase-
contrast video microscope (Leica) equipped with a CCD camera
(Zeiss).
Results
Morphological Analysis
Isolated SVF cells from adipose tissue were directly plated in
semisolid methylcellulose medium (MethoCult GF M3534)
without previous cell expansion or culture selection. From 6
days of culture, emergence of various cell morphologies were
identified: clusters of preadipocytes/adipocytes, large spread-
ing cells with a highly branched shape and fibroblast-like
appearance (data not shown), and clones of rounded cells
together with small tube cells (Figure 1, day 10). From the
latter, some rounded cells independently started a contractile
activity at days 11 to 14 after plating. Within a few days,
myotube-like structures appeared, grew in size and prolifer-
ated, and were still surrounded by some of the rounded cells
(Figure 1, day 17). After 20 to 30 days, the areas gave rise to
a cohesive group of cells, with the presence of branching
fibers and sharing tight connections. At this time, the entire
area was beating at a single rate (Figure 1, day 24). The
emergence of contracting clones was independent of the
presence of 5-aza-2-deoxycytidine and occurred whatever
the tested adipose deposit was. However, the percentage of
beating clones counted at day 20 varied according to the
localization of the adipose tissue used to prepare SVF cells
(from 0.02% to 0.07% of plated naïve SVF cells purified
from interscapular and inguinal deposits, respectively). An-
other observation was that after starting beating, cells could
be maintained for a long time (several months) in methylcel-
lulose or in standard liquid medium.
Evidence for Cell Development Into Various
Cardiac-Like Phenotypes
In order to define the phenotype of contracting cells at
molecular level, clones were picked up from methylcellulose
culture by micropipette. Expression of several cardiac-
specific genes was assessed using RNAs from atrium and
ventricle as positive control. Figure 2 showed that beating
Figure 2. Expression of cardiac-specific genes and lack of skel-
etal mRNA in cells from contracting clones analyzed by
RT-PCR. Cells from contracting clones were picked up and
gene expression was compared with control cells from mouse
heart (ventricle or atrium) and muscle. RT-PCR of indicated
gene (lane 1) compared with -actin control (lane 2) and to
RT-negative control (lane 3) was performed. Expression of
cardiac-specific mRNA, ie, GATA4, Nkx 2.5, ANP, MLC-2v, and
MLC-2a was evidenced whereas MyoD mRNA was not
detected. Results are representative of 3 to 5 separate
experiments.
Figure 1. Phase-contrast microscopy of contracting clones at
days 10, 17, and 24. Isolated SVF cells were plated into methyl-
cellulose (7000 cells per milliliter) and observed every 2 days
under an inverted phase-contrast microscope at 2.5 (A), 10
(B), and 20 (C). Clones gradually increased in size with time
due to cell proliferation. Early cells were rounded (day 10), then
elongated cells appeared (day 17), and the mature clone was
essentially composed of aligned and branched myofibrils (day
24).
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clones expressed several cardiac-specific mRNA such as
transcription factors, GATA-4 and Nkx2.5, the ventricular
and atrial myosin light chain MLC-2v and MLC-2a, respec-
tively, and a secretion product, the atrial natriuretic peptide
(ANP). Muscle phenotype can be excluded because of the
lack of MyoD mRNA detection (Figure 2). These data
strongly argued for the cardiomyocyte nature of the contract-
ing cells.
To further characterize cells present in contracting areas,
immunocytochemistry experiments were performed. A spe-
cific positive staining was obtained with antibodies against
the myosin-enhancing factor 2C (MEF2C, Figure 3a), the
sarcomeric -actinin (Figure 3b), the contractile protein
MLC-2v (Figures 3c and 3d), the -myosin heavy chain
(MHC, Figures 3e and 3f), and connexins (Figures 3g and
3h). In contrast, antibodies raised against the skeletal muscle
protein MyoD (Figure 3i) or the smooth muscle actin (Figure
3k) did not stain the contracting cells compare to positive
controls, ie, differentiated C2C12 cells (Figure 3j) and mes-
enchymal bone marrow–derived myofibroblasts (Figure 3l),
respectively. Consistent with RT-PCR studies, these results
supported that cells identified in contracting clones were
cardiomyocyte and not skeletal or smooth muscle cells.
In respect to cell shape and protein detected, the pattern of
myofibrillar assembly was then analyzed by ultrastructural
analysis (Figure 4). Electron microscopy revealed mononu-
clear cells and multinuclear cells (Figures 4A and 4E) with
myofibrillar bundles oriented in a regular manner (Figures 4B
and 4C). Nuclei of these multinuclear cells presented very
similar morphology: nuclei were in the center of the myo-
tubes with multiple nucleoli and laxe chromatin (Figures 4B
and 4E). Cytoplasm had long mitochondria but presented a
few organelles. Nuclei with a wrinkled surface and invagina-
tions were also detected. Cells contain myofibrils with the
definitive ultrastructure of an organized sarcomere with
typical cross-striation and developed Z bands (1.2 to 1.3 m)
as shown in Figure 4D. The degree of myofibrillar organiza-
tion varied within different areas and in certain areas, cell
bifurcations further suggested these multinucleated cells to be
cardiomyocytes.
In conclusion, such clonogenic culture conditions pro-
moted SVF-derived cells to develop into ventricle-like cells
Figure 3. Immunostaining of contracting clone
cells for muscle-specific proteins. Cells in con-
tracting clones were specifically stained with anti-
myosin enhancing factor 2C (MEF2C) (a), anti-
sarcomeric -actinin (b), anti-myosin light chain-2v
(MLC-2v) (c and d), anti–-myosin heavy chain
(MHC) (e, f, and g, red), anti-connexin40 (g, blue),
and anti-connexin43 (h) antibodies. Tridimensional
representation of contractile proteins emphasized
cell ultrastructure (a through d and f). Red arrows
point out specific location of proteins (h). No spe-
cific staining was obtained with the anti-MyoD (i)
and anti-smooth muscle actin (k) antibodies com-
pared with positive controls labeling nuclei of dif-
ferentiated C2C12 cells (j, black arrows) and mes-
enchymal bone marrow–derived myofibroblasts (l,
black arrows). Results are representative of 3 to 6
separate experiments.
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(presence of MLC-2v and connexin43), atrial-like cells (pres-
ence of MCL-2a, ANP, and connexin40) and pacemaker
like-cells inducing the spontaneous contractions.
Evidence for Pacemaker Activity
To provide additional information regarding to the spontane-
ous beating activity, we performed electrophysiological stud-
ies very early in the time course of SVF cells culture (1 to 2
weeks after plating). At this time,, individualized cells could
independently be recorded in methylcellulose culture. Cellu-
lar electrical activity was recorded on cells in current-clamp
by using the whole cell configuration. Under current clamp,
adipose-derived cardiomyocytes displayed spontaneous as
well as triggered action potentials. Spontaneous electrical
activity (instantaneous frequency71Hz, n4) appeared
between 40 and 60 mV (Figures 5A and 5B). The
calculated characteristics of this pace maker activity were as
follows: peak amplitude685 mV, time-to-peak620.3
ms, half amplitude343mV, time-to-half-amplitude
rise601ms, and rise time 10% to 90%319 ms (n4).
The shape of this action potential was characteristic to cardiac
pacemaker cells.
Pharmacological Studies
To test the functionality of the putative cardiomyocytes, we
examined the chronotropic response of mature contracting
fibers to several agents known to control the heart rate.
Pharmacological studies were performed on 30-day-old beat-
ing cells where the ventricle-like morphology predominated.
As expected for cardiomyocyte-like cells, the -agonist
isoproterenol induced a dose-dependent increase of the spon-
taneous contraction rate measured as bpm (Figure 6A).
Propranolol, a nonselective -adrenergic antagonist, reversed
the isoproterenol-induced acceleration (Figure 6A). By con-
trast, increasing concentrations of carbamylcholine, a nonse-
lective acetylcholine agonist, significantly decreased to fi-
nally stop the spontaneous contractions (Figure 6B). Stopped
cells started again to contract when atropin, a muscarinic
antagonist, was added (Figure 6B). These chronotropic re-
sponses definitively demonstrated that these cells responded
like functional cardiomyocyte-like cells. When analyzing the
behavior of the different clones, a great heterogeneity ap-
peared in the sensitivity to the different drugs. For instance,
some cells that did not contract in control experiment started
to beat under -adrenergic stimulation (data not shown).
However, when cells were responsive, similar pattern toward
the drugs was always observed.
Discussion
This study is the first one to describe the spontaneous
emergence of functional cardiomyocyte-like cells from adult
tissues in primary culture. All molecular and functional
Figure 4. Ultrastructural analysis of contractile clone cells. Iso-
lated SVF cells were plated in methylcellulose for 20 days, and
transmission electron micrographs of SVF-derived beating colo-
nies were performed and represented: semi-thin cut (A) low-
power transmission electron micrographs (B and C), high-power
micrograph with organized sarcomere between Z-lines (D), and
low-power transmission electron micrographs that reconstitute
an entire fiber (E).
Figure 5. Electrophysiological analysis of early contractile clone
cells. Generation of spontaneous action potential after applica-
tion of a potential of 60 mV. Firing rate was 66 bpm (A).
Details of 3 individual action potentials (B).
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features are consistent with this conclusion and definitively
exclude skeletal or smooth muscle phenotype. SVF-derived
cells failed to express the skeletal marker MyoD and the
smooth muscle actin. In contrast, these adipose tissue-derived
cells expressed the cardiac-specific transcription factors
Nkx2.5, GATA4, and MEF2C, the structural cardiac protein
MHC, as well as late-stage cardiac specification proteins
MLC-2v, MLC-2a, and ANP.
Our results identified various cell shapes all along the clone
development that could correspond to the shift cardiomyocyte
undergoes from early to terminally differentiated stages. Early
cells in contracting areas were roundish myocytes and changed
into elongated fibers with sarcomeric-organized myofibrils. The
morphological heterogeneity observed could also be correlated
with the contractile proteins rearrangement occurring during cell
maturation. For instance, myosin MLC-2v and MHC organi-
zation evolved from circular or spots in rounded early cells
(Figures 3c and 3e) to complete sarcomeric structures and
oriented fibers in elongated differentiated cells (Figures 3d
through 3f). In very late cultures, mature contractile cells were
linked by tight connections evidenced with the presence of
connexins (Figure 3). Furthermore, at early stage of differenti-
ation, they displayed electrophysiological properties (ie,
pacemaker-like activity), characteristic of intermediate stage
cardiomyocytes as previously defined in embryonic stem cell-
derived cardiomyocytes.17
In contrast to all previous reports on medullar mesenchy-
mal stem cells in vitro, this cardiomyocyte differentiation was
achieved with the lack of 5-azacytidine as described for
cardiomyocyte differentiation of embryonic stem (ES)
cells.6,17 Compared with cell culture usually performed in
liquid medium, we chose the semisolid methylcellulose
medium known to support hematopoietic clonogenic expan-
sion that allowed 3-dimensional structure and microconcen-
tration of cells.18 Although the nature of the medium pro-
moted contractile clone development, it cannot by itself
explain our results. The same culture conditions failed to
reveal cardiomyocyte potential of murine bone marrow
stroma cells (data not shown). In addition, beating cells were
observed in liquid medium even though the occurrence of
such event was rare. To argue about the role of hematopoietic
cytokines present in the methylcellulose medium, ie, IL3,
IL6, and SCF, preliminary data suggested they were not
absolutely required but seemed to enhance cardiomyocyte-
like cells differentiation. Preliminary experiments indicated
that contracting clone differentiation was achieved in mini-
mum as well as in complete methylcellulose medium. The
major difference came from the size and the emergence that
was delayed in the very first steps when cultured in minimum
medium. However, no more significant differences were
observed between minimum and complete methylcellulose
culture conditions at day 20 after plating. Nevertheless,
cytokine effects and their interplay need further investigation
to be finely characterized.
Previous reports described adipose tissue as a possible
source of pluripotent stem cells and the differentiation of SVF
cells toward the osteogenic, adipogenic, myogenic, neuro-
genic, chondrogenic, and hematopoietic lineages.13,19 Our
data are consistent with these findings. The cardiomyocyte
phenotype was spontaneously obtained from cells derived
from adipose tissues raising the hypothesis that putative
cardiogenic progenitors reside in the tissue ready to express
their potential in some specific conditions that need to be
determined. Thus, a better understanding of cardiomyocyte
differentiation from adipose-derived cells is required to fore-
see the use of adipose stroma–derived cardiomyocytes in cell
based therapy of heart failure.
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